Healthtech Talks with Fexingo: Digital Health, Telemedicine, and Medical Software

Episode 11 of Healthtech Talks with Fexingo dives into the quiet automation revolution happening behind the pharmacy counter. Lucas and Luna explore how pharmacy robotics—from McKesson's centralized pill-packing systems to nimble pharmacy-dispensing kiosks from companies like MedAvail—are transforming the prescription-filling process. They discuss how the pandemic labor crunch accelerated adoption, why independent pharmacies are partnering with robotic vendors to compete with chains, and how these machines free up pharmacists for clinical consultations instead of counting pills. The episode uses specific data: how a typical robotic system can fill 300+ prescriptions per hour versus 30 manually, and what that means for error rates and cost per script. It also touches on regulatory hurdles, including state-level technician-to-pharmacist ratio laws. The hosts close by considering whether fully autonomous pharmacies are feasible or if the human element remains essential. A listener-support segment is woven in near the end.

#PharmacyRobotics #MedicationAutomation #McKesson #MedAvail #PharmacyWorkflow #PrescriptionFilling #Healthtech #DigitalHealth #Business #Technology #FexingoBusiness #BusinessPodcast #LucasAndLuna #HealthtechTalks #PharmacistBurnout #Automation #Robotics #HealthcareInnovation

Keep every episode free: buymeacoffee.com/fexingo

Episode 10 of Healthtech Talks unpacks the hidden machinery behind automated claims denials in U.S. health insurance. Lucas and Luna examine the case of a major insurer whose algorithmic system rejected 30 percent of emergency room claims between 2020 and 2025, leading to a class action lawsuit and new state-level transparency rules. They walk through how the algorithm works, the false-positive rate, and the regulatory pushback now forcing insurers to audit denial logic. The hosts also discuss the broader tension between cost control and patient care, and what the rise of algorithmic adjudication means for startups building prior authorization software. A focused look at the intersection of AI, insurance liability, and health policy in 2026.

#HealthInsurance #AlgorithmicDenials #ClaimsAutomation #PriorAuthorization #AIinHealthcare #HealthPolicy #InsuranceRegulation #PatientRights #DenialManagement #UtilizationReview #HealthcareCosts #DigitalHealth #Healthtech #BusinessAndTechnology #FexingoBusiness #BusinessPodcast #HealthtechTalks #PodcastEpisode

Keep every episode free: buymeacoffee.com/fexingo

In this episode of Healthtech Talks, Lucas and Luna explore the emerging world of digital therapeutics — software-based treatments that are now winning FDA approval for conditions like chronic insomnia, ADHD, and substance use disorder. They focus on one standout case: Pear Therapeutics' reSET-O, the first prescription digital therapeutic for opioid use disorder, and discuss how the FDA evaluates these tools, the challenges of reimbursement, and what the approval pipeline looks like in mid-2026. Along the way, they touch on the pivotal role of real-world evidence and why some payers are still hesitant. Whether you're a clinician, a healthtech founder, or just curious about where medicine is headed, this episode offers a concrete look at a category that's quietly reshaping what 'treatment' means.

#DigitalTherapeutics #PearTherapeutics #FDACleared #PrescriptionSoftware #REVAMP #OpioidCrisis #InsomniaTreatment #ADHD #RealWorldEvidence #Reimbursement #Healthtech #Business #Technology #FexingoBusiness #BusinessPodcast #HealthtechTalks #LucasAndLuna #ClinicalValidation

Keep every episode free: buymeacoffee.com/fexingo

Episode 8 of Healthtech Talks digs into the real-world impact of remote patient monitoring (RPM). Lucas and Luna examine a landmark study from the Journal of the American Medical Association showing that RPM programs reduced 30-day hospital readmissions by 38 percent among heart failure patients. They explore the specific technology stack — Bluetooth-enabled scales and blood pressure cuffs paired with a centralized dashboard — and the behavioral economics nudges that made patients actually use the devices. The conversation also touches on how Medicare's expanded reimbursement codes for RPM in 2024 finally made the economics work for health systems. A focused look at one concrete number and the infrastructure behind it.

#RemotePatientMonitoring #RPM #Healthtech #HospitalReadmissions #HeartFailure #Telemedicine #Medicare #Reimbursement #DigitalHealth #PatientEngagement #BluetoothScales #BloodPressureCuffs #BehavioralEconomics #JAMA #ClinicalOutcomes #Business #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna explore how digital twin technology is transforming clinical trials, saving time and money while improving patient outcomes. They break down how companies like Unlearn.ai and Siemens Healthineers use AI-powered synthetic control arms to replace placebo groups, reducing trial sizes by up to 40%. The hosts discuss a 2025 study showing that a digital-twin-informed trial for a diabetes drug produced results equivalent to a 1,200-patient trial with just 800 real participants, cutting costs by roughly $50 million. They also examine regulatory hurdles and ethical questions: How accurate does a twin need to be to replace a human? What happens when a trial's synthetic data conflicts with real-world outcomes? Lucas and Luna keep it grounded with specific numbers and avoid hype, treating listeners as smart but time-pressed professionals who want one concrete insight they can use tomorrow.

#DigitalTwins #ClinicalTrials #HealthTech #AI #UnlearnAI #SiemensHealthineers #SyntheticControlArms #DrugDevelopment #Pharmaceuticals #MedicalSoftware #TrialDesign #RegulatoryScience #FDA #MachineLearning #HealthcareInnovation #Business #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

Episode 6 of Healthtech Talks with Fexingo: Lucas and Luna dive into the rise of AI-powered mental health chatbots, focusing on a specific case study: Woebot Health. They explore how these conversational agents handle high-volume cognitive behavioral therapy (CBT) exercises, reducing the burden on human therapists. Lucas cites a 2025 JAMA study showing that patients using Woebot for 8 weeks saw a 32% reduction in depression symptoms, comparable to traditional therapy. Luna questions whether chatbots can handle crisis situations and points to recent FDA guidance on AI in mental health. The hosts also examine the business model: Woebot's B2B partnerships with employer health plans, which have grown 40% year-over-year since 2023. They close by considering the ethical implications of scaling therapy through software. No fluff, just the numbers and the human impact.

#MentalHealthChatbots #WoebotHealth #DigitalTherapy #CBTAI #JAMAStudy #TherapistBurnout #Healthtech #Telemedicine #BusinessPodcast #FexingoBusiness #AIinHealthcare #DepressionTreatment #CognitiveBehavioralTherapy #FDA #EmployerHealthPlans #BehavioralHealth #StartupScaling #VentureCapital

Keep every episode free: buymeacoffee.com/fexingo

When COVID-19 lockdowns hit, rural hospitals faced an impossible choice: shut down or find a way to treat patients remotely. This episode digs into the story of a 25-bed critical access hospital in central Kansas that adopted telemedicine in 2020 and not only survived but expanded services. We walk through the specific technology stack they used, the regulatory waivers that made it possible, and the surprising financial outcome: a 40 percent reduction in emergency department transfers to urban centers. Lucas and Luna also discuss the lasting policy changes, including the Medicare Telehealth Flexibilities Act of 2024, and what it means for the next wave of digital health adoption in underserved areas. No hype, just the numbers and the human impact.

#Telemedicine #RuralHealth #CriticalAccessHospital #DigitalHealth #HealthTech #Medicare #COVID19 #Kansas #Policy #HealthEquity #RemotePatientMonitoring #TelehealthFlexibilities #Business #Technology #HealthInnovation #FexingoBusiness #BusinessPodcast #HealthtechTalks

Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna explore the rapidly evolving world of AI-powered dermatology. They focus on a landmark 2025 study published in The Lancet Digital Health, where a deep learning model trained on over 100,000 dermoscopic images matched or beat board-certified dermatologists in diagnosing melanoma, basal cell carcinoma, and squamous cell carcinoma. The conversation drills into how these models work under the hood — convolutional neural networks trained on labeled image datasets — and why regulatory hurdles at the FDA and European MDR are slowing clinical adoption. Lucas explains the specific sensitivity and specificity numbers from the study, while Luna questions whether training data diversity issues could create blind spots for darker skin tones. They also discuss the startup landscape, including companies like SkinVision and DermEngine, and whether AI will replace or augment human dermatologists. No hype, just the data and the open questions.

#AI #Dermatology #SkinCancer #DeepLearning #MedicalImaging #Melanoma #RegulatoryApproval #FDA #DigitalHealth #Healthtech #LancetDigitalHealth #SkinVision #DermEngine #CNN #ClinicalValidation #BusinessAndTechnology #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna dive into the landmark Apple Heart Study, published in 2019, which enrolled over 400,000 participants in eight months. The study used an irregular pulse notification algorithm on the Apple Watch to detect atrial fibrillation, the most common heart arrhythmia and a leading cause of stroke. Lucas explains the study's design, its 84% positive predictive value, and why only 0.5% of participants received notifications. Luna questions the implications for consumer health devices and regulatory oversight. They discuss how this single study shifted the conversation around wearable diagnostics, prompted FDA clearances, and influenced the broader digital health landscape. The episode explores whether a smartwatch can responsibly screen for a condition that often goes unnoticed until it's too late.

#AppleHeartStudy #AppleWatch #AtrialFibrillation #WearableTech #DigitalHealth #Cardiology #HealthTech #IrregularPulse #Stanford #FDA #ClinicalStudy #StrokePrevention #ConsumerHealth #Podcast #FexingoHealthtech #FexingoBusiness #BusinessPodcast #MedTech

Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna dive into the growing trend of direct primary care (DPC) — a subscription-based model where patients pay a monthly fee for unlimited primary care visits. They examine how companies like One Medical (now part of Amazon) and independent DPC clinics are disrupting traditional fee-for-service medicine. With specific data on cost savings — DPC patients save an average of 25% on total healthcare spending — and an example of a Kansas City clinic that cut ER visits by 40%, they explore why employers and insurers are starting to partner with DPC providers. The hosts also unpack the regulatory hurdles and the debate over whether DPC worsens physician shortages. A focused look at a model that could redefine how millions access basic healthcare by 2026.

#DirectPrimaryCare #HealthcareDisruption #SubscriptionMedicine #PrimaryCare #OneMedical #AmazonHealth #FeeForService #ValueBasedCare #HealthInsurance #EmployerSponsoredHealth #HealthcareCosts #Telemedicine #Healthtech #Business #FutureOfMedicine #FexingoBusiness #BusinessPodcast #HealthtechTalks

Keep every episode free: buymeacoffee.com/fexingo